---
layout: default
nav_exclude: true
title: 2-Deoxy-D-Glucose
---

# 2-Deoxy-D-Glucose

**Generic Name:** 2-Deoxy-D-glucose (2-DG)

**Usage:**

2-DG is primarily used in research settings and is currently under investigation for several therapeutic applications.  It's not approved by the FDA (or similar bodies in other countries) for widespread clinical use, except in very limited, specific circumstances. Its most explored application is as an **anti-cancer agent**.  It's also being researched for its potential use in treating:

* **Infections:**  Specifically, viral infections, by interfering with viral replication.
* **Neurodegenerative diseases:**  Though early-stage research.
* **Diabetes:**  Again, largely experimental, and primarily used to study glucose metabolism.


**Side Effects:**

The side effects of 2-DG vary depending on the dosage and route of administration. Reported side effects include:

* **Gastrointestinal issues:** Nausea, vomiting, diarrhea.
* **Neurological effects:**  Headache, dizziness, confusion (more likely at higher doses).
* **Metabolic disturbances:**  Changes in blood glucose levels (hypoglycemia or hyperglycemia), alterations in lipid metabolism.
* **Hepatotoxicity:**  Liver damage (rare, but a concern at high doses).
* **Nephrotoxicity:**  Kidney damage (rare, but a concern at high doses).


**How it Works:**

2-DG is a glucose analog. This means it's structurally similar to glucose, but it lacks a hydroxyl group on the 2' carbon.  This subtle difference prevents it from being fully metabolized by cells.

1. **Cellular Uptake:**  Cells take up 2-DG via glucose transporters, mistaking it for glucose.
2. **Inhibition of Glycolysis:**  2-DG is phosphorylated to 2-deoxyglucose-6-phosphate (2-DG-6-P) by hexokinase. However, unlike glucose-6-phosphate, 2-DG-6-P cannot be further metabolized in glycolysis. This leads to a buildup of 2-DG-6-P, inhibiting glycolysisâ€”the primary pathway for glucose metabolism.
3. **Cancer Cell Targeting:** Cancer cells typically rely heavily on glycolysis for energy production (Warburg effect).  By inhibiting glycolysis, 2-DG aims to starve cancer cells of energy and prevent their growth and proliferation.
4. **Viral Replication Inhibition:**  Viruses also often rely on host cell glycolysis.  Therefore, 2-DG can interfere with viral replication.


**FAQs:**

* **Is 2-DG FDA-approved?** No, not for widespread clinical use.  Its use is largely limited to research and specific clinical trials.
* **Is 2-DG safe?**  The safety profile of 2-DG is not fully established, and side effects are possible, particularly at higher doses.
* **How is 2-DG administered?** Administration methods vary depending on the research application and can include intravenous, oral, or topical routes.
* **What are the long-term effects of 2-DG?**  Long-term effects are not well-understood due to the limited clinical use and ongoing research.
* **Is 2-DG effective?**  The effectiveness of 2-DG is still under investigation, and results from clinical trials have been mixed.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Consult a healthcare professional before using or considering 2-DG for any health condition.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.